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1. Ocular surface squamous neoplasia  
Human ocular surface squamous neoplasia (OSSN) is the most common ocular surface pre-
cancerous and cancerous lesion previously known by various names such as conjunctival 
intraepithelial neoplasia, corneal intraepithelial neoplasia (CIN), or both together (CCIN) 
(Grossniklaus et al., 1987). Clinically, OSSN manifests in different grades ranging from 
simple dysplasia to squamous cell carcinoma (Grossniklaus et al., 1987). Because of the high 
incidence of OSSN in the limbal area, where the corneal epithelial stem cells are located, the 
limbal transition zone/stem cell theory has been proposed for the development of CIN by 
Lee and Hirst (Lee and Hirst, 1995). Tseng and co-investigators have suggested that the slow 
cycling limbal stem cells may become hyper-proliferative by stimulations such as alterations 
in this anatomic site influenced by other factors, e.g., carcinogens, irradiation (eg, UVB), and 
the phorbol ester tumor promoter, 12-O-tetradecanoylphorbol 13-acetate (TPA) (Tseng, 
1989), which can cause abnormal proliferation of the conjunctival and corneal epithelium 
and lead to the formation of CIN. Nevertheless, the etiology and pathogenesis of CIN and 
ocular surface carcinoma remain elusive. To date, there is no appropriate animal model 
available to study the molecular and cellular mechanisms of this disease. Therefore, the 
availability of such animal model will not only aid to understand the pathogenesis but also 
yield a more effective treatment for OSSN.  
2. Generation Krt12
rtTA
/tet-O-FGF-7 bi-transgenic mice and induction of FGF-7 
overexpression by doxycycline 
It has been well documented that the mouse Krt12 gene expression is restricted to the 
differentiated corneal epithelium (Liu et al. 1993, 1994). To generate a corneal epithelium-
specific and Dox-inducible transgenic driver mouse line, we have genetically introduced 
(“knock-in”) an ires-rtTA (internal ribosome entry site-reverse tetracycline transactivator) 
cDNA into the 3’-untranslated region of themouse Krt12 gene locus via conventional gene-
targeting techniques (Chikama et al., 2005). The resulting transgenic mouse line was 
designated as Krt12rtTA, in which like K12 expression pattern, the rtTA is constitutively and 
specifically expressed by the corneal epithelium. The Krt12rtTA mouse line was then crossed 
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with the tetO-FGF-7 mouse line (a gift from Dr. Jeffrey Whitsett, Cincinnati Children’s 
Hospital Medical Center, Tichelaar et al., 2000) to generate the Krt12rtTA/rtTA/tet-O-FGF-7 bi-
transgenic mouse strain. To induce FGF-7 expression, mice were injected once intra-
peritoneally with Dox (80 μg/g body weight; Clontech Laboratories) dissolved in PBS (pH 
7.4) at a concentration of 10 mg/ml and fed Dox-chow (1 g/Kg chow, Bioserv, Frenchtown, 
NJ). Control animals were fed regular chow. As shown in Figure 1, FGF-7 over-expression 
can be induced by doxycycline (Dox) induction and results in a phenotype resembling 
OSSN (Chikama et al., 2008).  This bi-transgenic mouse line may serve as an animal model 
for understanding the relationship between signaling pathway and the pathological 
progression of this disease. 
 
Fig. 1. Over-expression of FGF-7 resulted in OSSN in Cornea. A). Diagram showing that 
corneal epithelium-specific induction of FGF-7 by Dox in Krt12rtTA/rtTA/tetO-FGF-7 bi-
transgenic mice. B) K12rtTA /tetO-FGF-7 bi-transgenic mice exposed to Dox through mother 
fed doxycycline chow in the dam since post-nantal day1 (P1) showed corneal intra-epithelial 
neoplasia at P21 (Bb, Bd) compared to age-matched non-induced mice (Ba, Bc). Papilloma-
like epithelial lesion with mesenchymal invasion was found mainly in the peripheral/limbal 
region (Be, Bf).  
3. FGF-7 over-expression and ocular surface carcinogenesis  
FGF-7 is a potent mitogen for epithelial cells (Panos et al., 1993; Rubin et al., 1989). The 
pattern of expression of FGF-7 and its receptor suggest that FGF-7 serves as a paracrine 
produced by mesenchymal cells in modulating epithelial cells during embryonic 
development and the maintenance of homeostasis in adults (Finch et al., 1995). FGF-7 
enhances epithelial cell proliferation in various organs (Finch et al., 1989, Rubin et al., 1995). 
Interestingly, aberrant up-regulation of FGF-7 has been reported to be associated with many 
human neoplastic tumors of epithelial cell origin (Cho et al., 2007; Manavi et al., 2007; 
Hishikawa et al., 2004; Mehta et al., 2000; Kovacs et al., 2006; Niu et al., 2007). Human 
papilloma virus 16 (HPV16) and long-term UV irradiation are the major risk factors for 
corneal intraepithelial neoplasia (Napora et al., 1990). Interestingly, it has been 
demonstrated that FGF-7 level within the cancer lesion was elevated throughout the 
progression of multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice (Arbeit 
et al., 1996; Pietras et al., 2008). It has been reported that the exposure to UVB irradiation can 
induce a rapid intracellular production of ROS (reactive oxidative stress), which in turn is 
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capable of triggering phosphorylation and activation of the FGF-7 receptor, FGFR2-IIIb, 
similar to those induced by FGF-7 (Marchese et al., 2003). These results lead to our 
hypothesis that aberrant activation of FGF-7 signaling pathway(s) may be accountable for 
tumorigenesis derived from limbal stem cells that undergo oncogenic transformation by 
insults such as long-term UVB exposure and/or infection of HPV etc, which exhibit the 
characteristic phenotypes of OSSN (Scott et al., 2002; Karp et al., 1996; Kiire et al., 2006). The 
FGF-7/FGFR signaling is likely the hub that integrates the input through UVB and HPV 
with the genesis and formation of OSSN (Figure 2). This may explain why excess FGF-7 
caused OSSN phenotype in the Dox-treated Krt12rtTA/rtTA/tet-O-FGF-7 bi-transgenic mouse 
model (Chikama et al., 2008). 
 
 
 
 
 
 
 
Fig. 2. Hypothetical schema showing that FGF-7/FGFR2 signaling can be activated by UVB 
and/or HPV type 16, two major risk factors for human OSSN. HPV16 transgene was known 
to be able to up-regulate FGF-7 (Artbeit et al., 1996). On the other hand, UVB can induced 
intracellular ROS which in turn phosphorylated and activated FGFR2-IIIb (Marchese et al., 
2003). 
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The precise spatio-temporal expression of FGF-7 is important for ocular surface tissue 
morphogenesis. FGF-7 are secreted by mesenchymal cells, which bind with high affinity to 
the same FGF receptor 2 (FGFR2-IIIb) isoform expressed mainly by the epithelial cells 
(Igarashi et al., 1998). In cornea, expression of FGF-7 and its cognate receptor FGFR2-IIIb is 
higher in limbal stroma and epithelium, respectively, than in the central cornea, implicating 
that FGF-7 may promote limbal stem cell proliferation and participate in modulation of 
corneal epithelium renewal and homeostasis (Li and Tseng, 1996, 1997). However, excess 
FGF-7 are capable of altering epithelial fates during embryonic development. For example, 
over-expression of FGF-7 driven by A-crystalline promoter, which is activated in mouse 
lens at E11.5, resulted in the suppression of cornea-type epithelial differentiation and the 
induction of ectopic lacrimal gland formation in the corneas of the transgenic mice 
(Makarenkova et al., 2000; Govindarajan et al., 2000; Lovicu et al., 1999). In order to 
understand such an influence at a later stage when epithelial cells have undergone corneal 
type epithelial differentiation, we developed a Krt12rtTA/rtTA/tetO-FGF-7 bi-transgenic mouse 
line in which over-expression of FGF-7 by Dox induction caused squamous cell carcinoma of 
the cornea resembling OSSN in human (Chikama et al., 2008). Less is known, however, 
about the signaling pathways by which FGF-7 mediates control of corneal epithelial cell 
proliferation.  
4. FGF signaling pathway and its action in mammalian cells  
FGF signaling, which is involved in the control of cell proliferation, differentiation, 
migration, survival and polarity, is transduced through FGF receptors (FGFR). FGFR1, 
FGFR2, FGFR3 and FGFR4 are FGF receptors, consisting of an extracellular 
immunoglobulin-like (Ig-like) domain and a cytoplasmic tyrosine kinase domain (Lee et al., 
1989; Dionne et al., 1990; Partanen et al., 1990, 1991; Powers et al., 2000; Katoh and Katoh, 
2003). FGF receptor isoforms with distinct ligand affinity are generated by alternative 
splicing of mutually exclusive exons in the latter half of the third Ig-like domain. FGF 
dimers associated with heparan sulfate proteoglycan bind to FGF receptors to induce 
receptor dimerization and receptor auto-phosphorylation. FGF signals are transduced via 
multiple signaling pathways such as the mitogen-activated protein kinases (MAPK), the 
phospholipase-C gamma (PLC), and the PI3K-PKB/AKT (Eswarakumar et al., 2005; Dailey 
et al., 2005; Katoh and Katoh, 2006; Kouhara et al., 1997; Ong et al., 2000) (Figure 3). A key 
component of FGF signaling is the docking protein called FGFR substrate 2 (FRS2) which is 
phosphorylated on tyrosine residues upon FGF stimulation. FRS2 consists of N-terminal 
myristylation signal, phosphotyrosine binding (PTB) domain and C-terminal region with 
multiple Src homology-2 (SH2) binding sites. FRS2 is recruited to the auto-
phosphorylated FGF receptors through the interaction with phospho-tyrosine residues. 
FRS2, bound to auto-phosphorylated FGFRs, is tyrosine phosphorylated in the C-terminal 
region, which in turns recruits growth factor receptor-bound protein 2 (GRB2) and a SH2-
containing tyrosine phosphatase, SHP2. In most cell types, FRS2-GRB2-SHP2 signaling 
complex recruits the guanine nucleotide exchange factor, Son of sevenless (SOS), which 
activates Ras and downstream effectors of MAPK (Figure 3, highlighted in grey). The 
MAPKs which include ERKs, p38, and Jun N-terminal kinases (JNKs) regulate the activity 
of downstream kinases or transcription factors. Although MAPK family shares many 
structural similarities, the ERK1/2 kinases are generally considered responsible for the 
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mitogenic response, while the p38 and JNK are usually associated with inflammatory or 
stress-responses (Johnson et al., 2002).  
Alternatively upon FGF stimulation, FRS2-SHP2-GRB2 complex may recruit GRB2-
associated binding protein 1 (GAB1) to activate PI3K (Figure 3, highlighted in yellow), 
which phosphorylates PIP2 to generate phosphatidylinositol-3,4,5-triphosphate (PIP3) (Ong 
et al., 2002; Cantley, 2002). PIP3 induces the translocation of PKB/AKT to plasma 
membrane, where PKB/AKT is phosphorylated and activated by phosphoinositide-
dependent kinase (PDK) (Luo et al., 2003). The ability of FGFs to protect cells from apoptosis 
is primarily due to the activation of the PKB/AKT survival pathway, a PI3K dependent 
activation of PDK, leads to the activation of PKB/AKT which in turn attenuates the activity 
and/or suppression of pro-apoptotic factors (Schlessinger, 2000 Schlessinger. PKB/AKT 
phosphorylates a variety of substrates, such as glycogen synthase kinase (GSK-3), forkhead 
transcription factor (FKHR), FOXO1 (Burgering and Medema, 2003). It is of interest to note 
that inhibition of GSK-3 via phosphorylation its Ser-9 by activated PKB/AKT and provides 
additional anti-apoptotic protection (Jope and Johnson, 2004) and possibly the accumulation 
and nuclear translocation of -catenin. Furthermore, a wide variety of agents, e.g., SB-
216763, SB-415286, and LiCl, is known to attenuate GSK-3 activities via phosphorylation at 
Ser-9 by PKB/AKT and allow the accumulation and nuclear translocation of transcription 
factor -catenin (Frame and Cohen, 2000). 
FGF signal also activates phosphatidyl inositol (Pt Ins) hydrolysis, release of intracellular 
calcium and activation of protein kinase C (PKC) via recruitment of the SH2 domain of PLC 
to the FGFR. Activated PLC hydrolyzes Pt Ins [4,5] P2 to form diacylglygerol (DAG) and 
Ins [1,4,5] P3 which stimulates calcium release and activation of calcium/calmodulin 
dependent protein kinases (Figure 3, highlighted in blue). The loss of this pathway does 
notappear to impair the proliferative response (Mohammadi et al., 1992). It remains 
unknown which individual aforementioned signaling pathways and/or their combination is 
responsible for the patho-physiology of OSSN caused by excess FGF-7 in our 
Krt12rtTA/rtTA/tet-O-FGF-7 mice. 
5. Cross-talk between FGF and Wnt pathways may be mediated by common 
target proteins  
It has been shown that FGF and Wnt signaling pathways crosstalk takes place during a 
variety of cellular processes, such as embryogenesis (Loebel et al., 2003; McGrew et al., 1997; 
Tickle, 1995; Ng, 2002; Villanueva et al., 2002; Gunhaga et al., 2003; Shackleford et al., 1993) 
and carcinogenesis (MacArthur et al., 1995; Katoh, 2002; McWhirter, 1997, 1999; Kirikoshi et 
al., 2000; Shimokawa et al., 2003; Chamorro et al., 2005; Katoh and Katoh, 2005). A key event 
in the canonical Wnt pathway is the activation of -catenin that subsequently regulates 
transcription of specific target genes that modulate cell fate, proliferation, migration, and 
apoptosis. In the absence of Wnt signals, cytosolic -catenin is phosphorylated by GSK-3, 
which targets -catenin for proteasome-mediated degradation. However, in the presence of 
a Wnt signal, GSK-3 is inactivated by phosphorylation, and results in accumulation and 
nuclear translocation of stable -catenin that binds DNA elements of members of the 
lymphoid enhancer factor/T-cell factor (LEF/TCF) family of transcription factors. Thus, it 
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activates transcription of Wnt-target genes (Moon et al., 2002) (Figure 4). -catenin also 
functions at the cell membrane where, as a component of the adherent junction, it links 
cadherin to the cytoskeleton (Kemler et al., 1993).  
 
 
  
 
Fig. 3. FGF signal transduction pathways. Activated FGFRs (red rectangles) stimulate PLC 
pathway (blue highlight), the PI3K/PKB-AKT pathway (yellow highlight), and the FRS2-
Ras-MAP kinase pathway (grey highlight). The activated MAP kinases (ERKs, p38, or JNKs) 
are translocated to the nucleus where they phosphorylate (P) transcription factors, thereby 
regulating target genes. In some cell types, FGF signaling also phosphorylates the Shc and 
Src proteins. Abbreviations: PKB/AKT, protein kinase b; DAG, diacyl glycerol; ERKs, 
Extracellular signal-regulated kinases; FKHR, forkhead homolog 1; FRS2, Fibroblast growth 
factor receptor substrate 2; GAP, GTPase-activating protein; Gab1, Grb2-associated binding 
protein 1; GRB2, Growth factor receptor-bound protein 2; GSK-3, Glycogen synthase kinase 
3;MAPK,  Mitogen-activated protein kinase; JNKs, Jun N-terminal Kinases; PDK, 3-
phosophoinositide-dependent protein kinase;PI3K, Phosphoinositide 3-kinase; PKC, protein 
kinase C; PLC: phospholipase C gamma; Rac, Ras-related C3 botulinum toxin substrate; 
Shp2, Src homology 2-containing tyrosine phosphatase; SOS, Son of sevenless, guanine 
nucleotide exchange factor. 
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Fig. 4. Graphical depiction of the schema of the canonical Wnt signaling pathway. (Left 
panel) In the absence of Wnt ligand, LEF/TCF transcription factors are inert due to their 
association with a repressor (groucho protein) on their nuclear DNA binding sites. Beta-
catenin, which is needed for release of the repressor protein, is captured by a degradation 
complex containing casein kinase I alpha (CKI-), GSK-3, Axin, and adenomatosis 
polyposis coli (APC) before it can enter the nucleus and is phosphorylated by GSK-3 and 
subsequently ubiquitinylated and degraded by the proteasome (Right panel). When Wnt 
ligand binds to its receptors, Frizzled and LRP5/6, dishevelled (Dsh) protein becomes 
activated. Repression of GSK-3 by an alternative complex containing Dsh and GSK-3 
binding protein (GBP) releases -catenin from the aforementioned degradation complex. 
Unbound -catenin enters the nucleus to complex with LEF/TCF, displacing groucho and 
enabling formation of an active transcription complex. 
A possible candidate that can mediate both Wnt and FGF signalings is GSK-3, which can 
also be phosphorylated by PKB/AKT besides Dishevelled protein (Jope and Johnson, 2004). 
Evidence for this assertion has been provided during FGF-2 treatment of neuronal cells, 
which increases GSK-3 phosphorylation and nuclear localization of -catenin. Over-
expression of -catenin maintains neural progenitor cells in a proliferative state in the 
presence of FGF-2, but enhances neuronal differentiation in the absence of FGF-2, 
suggesting that FGF signaling regulates neural progenitor cell proliferation and also affects 
lineage commitment during neural differentiation, in part, via -catenin signaling (Israsena 
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et al., 2004). Similarly, in neural cells, the neuroprotective effects of FGF-1 may utilize GSK-
3 inactivation via activation of the PI3K-PKB/AKT cascade (Hashimoto et al., 2002). In 
addition, FGF-2-treated human endothelial cells show an increase in nuclear -catenin by a 
reduction in GSK-3 activity (Holnthoner et al., 2002). Although GSK-3 has been shown to 
be a phosphorylation target of FGF as well as other signaling pathways such as IGF, the 
consequences of altered GSK-3 activity on -catenin/LEF/TCF-dependent transcription 
seems to be cell-type dependent. For example in 293 embryonic kidney cells, IGF-mediated 
phosphorylation of GSK-3 does not lead to induction of LEF/TCF-dependent transcription 
(Playford et al., 2000). During early Xenopus development, FGF signaling leads to the 
inhibition of endogenous GSK-3 via a PKB/AKT independent p90RSK pathway (Torres et 
al., 1999). p90RSK over-expression increases the level of membrane-associated -catenin 
without fluctuation in nuclear levels. The fact that both FGF and Wnt signaling target a 
common protein implicates that the assignment of particular proteins such as GSK-3 to a 
specific ‘‘pathway’’ is arbitrary since their activity can be influenced by a number of 
different routes. Furthermore, since proteins such as GSK-3are targeted by several signal 
transduction pathways, they have the potential to act as molecular switches between these 
pathways, and thus serve as nodal points for pathway cross-talk (Figure 5). In addition, 
GSK-3 also binds to and phosphorylates the SNAIL transcriptional repressor, inducing its 
cytoplasmic translocation and degradation (Zhou et al., 2004). SNAIL represses E-cadherin 
transcription, a key tight junction molecule which establishes and maintains cell-cell 
adhesion (Batlle et al., 2000; Katoh and Katoh, 2005; Thiery and Sleeman, 2006). Taken 
together, these data support a model whereby the inhibition of GSK-3 activity via FGF-
dependent PI3K-PKB/AKT signaling leads to an epithelial-mesenchymal transition (EMT) 
through the down-regulation of E-cadherin. This results in the release of -catenin from the 
E-cadherin complex to promote nuclear accumulation of -catenin. It remains unknown 
which aforementioned pathway is employed or in combination in the corneal epithelium 
elicited by excess FGF-7. Further investigation should lead to a clear mechanistic event of 
FGF-7 signaling in corneal epithelium and tumor formation.  
6. Nuclear accumulation of the -catenin protein in tumors 
In human cancers, exon 3 of the CTNNB1 gene, which encodes -catenin, is a mutational 
“hot spot” for gain-of-function isoforms. This exon encodes the critical Ser/Thr residues, 
which are sites for priming by casein kinase1 (CK1) (Ser 45) and phosphorylation by GSK-3 
(Ser 33, 37 and Thr 41). As a result, this -transducin repeat-containing protein(-TrCP) 
recognition site marks -catenin for degradation. Therefore mutations within this exon 
increase the stability and nuclear accumulation of the -catenin protein. Indeed, somatic 
mutations in CTNNB1 gene are strongly associated with a wide variety of human tumors 
including colorectal carcinoma, desmoid tumor, endometrial carcinoma, hepatocellular 
carcinoma, hepatoblastoma, intestinal carcinoma gastric, medulloblastoma, melanoma, 
ovarian carcinoma, pancreatic carcinoma, pilomatricoma, prostate carcinoma, squamous cell 
carcinoma of the head and neck, thyroid carcinoma, and Wilms’ tumor (Polakis, 2000). To 
test the hypothesis that -catenin accumulation in corneal epithelial cell nucleus plays a 
pivotal role in mediating FGF-7 signaling networks leading to the formation of corneal 
neoplasia in Krt12rtTA/rtTA/tetO-FGF-7 bi-transgenic mice induced by Dox, we have crossed 
K12rtTA/rtTA/tetO-FGF-7/tetO-Cre mice with two different floxed Ctnnb1 mouse strains for the 
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analysis the role of -catenin in corneal intraepithelial neoplasia model. In the first mouse 
line, loxP sites flank an essential part (exon 2 through exon 6) of the Ctnnb1gene 
(Ctnnb1loxEx2-6) (Brault et al., 2001). Upon Cre-mediated recombination, the region containing 
exon 2 to 6 of the Ctnnb1 gene is deleted. This deletion causes a frame shift and premature 
termination of -catenin translation. As a result, no -catenin gene-product is produced 
from this allele. Interestingly, K12rtTA/rtTA/tetO-FGF-7/tetO-Cre/Ctnnb1loxEx2-6/loxEx2-6 tetra-
transgenic mice treated with Dox from P7 to P21 (i.e., short term induction for 14 days) 
failed to develop corneal epithelial hyperplasia, suggesting that this phenotype caused by 
excess FGF-7 is dependent on -catenin (Chia-Yang Liu et al., in preparation for 
publication).  
 
Fig. 5. Cross-talk between FGF and Wnt pathways. Elements of the FGF (yellow and red) 
and Wnt/-catenin (blue) pathways are shown. Depicted is how activation of the FGF 
receptor on the cell membrane can lead to activation of -catenin through different 
mechanisms. In some cell types, activation by FGF of either PI3K/AKT or MAP kinase/p90 
ribosomal S6 kinase (p90rsk) can promote GSK-3 phosphorylation, which is associated 
with translocation of -catenin to the nucleus. Inhibition of GSK-3b by Wnt, PI3K/AKt, or 
MAPK pathways suppressed the phosphorylation of Snail (green) and thus induces the 
nuclear localization and protein stabilization of Snail, which suppress E-cadherin and lead 
to cell migration. 
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In the second mouse line, loxP sites flank only exon 3 of the Ctnnb1gene (Ctnnb1floxedEx3) 
(Harada et al., 1999). Upon Cre-mediated recombination, exon 3 of the -catenin gene is 
deleted. Exon 2 is spliced in frame to exon 4 and thus a mutant protein designated as ΔE3 -
catenin is produced. However, this mutant protein lacks its phosphorylation sites which are 
necessary for the subsequent ubiquitinylation and degradation of -catenin. Therefore, this 
allele (Ctnnb1floxedEx3) encodes a more stable, constitutively dominant active -catenin protein 
mimicking the canonical Wnt signaling pathway. Indeed, Dox-treated K12rtTA/wt/tetO-
Cre/Ctnnb1floxedEx3/Wt tri-transgenic heterozygous mice all exhibited corneal epithelial 
hyperplasia at different developmental stages from P1 to P30. Moreover, X-gal positive cells 
completely correlated with the hyperplastic transformation and stromal invasion in the 
cornea of Dox-induced Krt12rtTA/wt/tetO-Cre/Ctnnb1floxedEx3/Wt/TOPgal quadruple transgenic 
heterozygous mice (Zhang et al., 2010). These results strongly indicate that regulation of -
catenin signaling plays a pivotal role in the maintenance of normal corneal epithelial 
homeostasis.  
7. Pespective 
Cornea is a unique and idea model for study angiogenesis and tumor progression in vivo 
because of its transparency and easy accessibility. Cornea consists of three cellular layers i.e., 
epithelium, stroma, and endothelium providing an idea model to study epithelium-
mesenchym transition. In addition, corneal epithelium is also unique as a stratified but not 
keratinized epithelium, which allows us to study the epithelial metaplasia. Human OSSN 
consists of a spectrum of dysplasia and/or neoplasia which is relatively common in clinical 
ophthalmology practice. Primary surgical excision and various adjunctive therapies such as 
mitomycin-C (MMC), 5-fluorouracil (5-FU), or interferon alpha-2b (INF-2b) remain as the 
mainstay of treatment but the recurrence rate is high. To improve the clinical outcome of 
OSSN treatment, agents aiming at the down regulation of signal transducing molecules that 
modulate -catenin are required. It is anticipated that signal transduction molecule(s), e.g., 
ERK→p90RSK→GSK-3→-catenin and/or PI3K→PKB/AKT→GSK-3→-catenin, which 
could mediate FGF-7 signaling networks responsible for the formation of corneal epithelial 
neoplasia will aid in the design of novel regimens for the treatment of human OSSN and 
other human cancers. 
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